Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Hepatology (Baltimore, Md.)
|
September 30, 2009
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
Simone Susser, Christoph Welsch, Yalan Wang, et al.
Endocrine Connections
|
September 28, 2023
Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?
Claire L Wood, Kieren G Hollingsworth, Edrina Bokaie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 25, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
Jia-Horng Kao, Youn-Jae Lee, Jeong Heo, et al.
Journal of Hepatology
|
November 28, 2012
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Colloid and Interface Science
|
September 12, 2012
Microfluidic preparation and self diffusion PFG-NMR analysis of monodisperse water-in-oil-in-water double emulsions
Eric Hughes, Abid Aslam Maan, Simone Acquistapace, et al.
Antiviral Therapy
|
August 28, 2015
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)
Christophe Hézode, Laurent Alric, Ashley Brown, et al.
Journal of Gastroenterology and Hepatology
|
August 8, 2015
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients
Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Hepatology
|
March 5, 2013
Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3
Marcelo O Silva, Michelle Treitel, Donald J Graham, et al.
Journal of Hepatology
|
July 20, 2014
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C
Jean-Pierre Bronowicki, Vlad Ratziu, Adrian Gadano, et al.
Hepatology (Baltimore, Md.)
|
September 25, 2014
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C
Tariq Ahmad, Philip Yin, Jeffrey Saffitz, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Hepatology (Baltimore, Md.)
|
September 30, 2009
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
Simone Susser, Christoph Welsch, Yalan Wang, et al.
Endocrine Connections
|
September 28, 2023
Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?
Claire L Wood, Kieren G Hollingsworth, Edrina Bokaie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 25, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
Jia-Horng Kao, Youn-Jae Lee, Jeong Heo, et al.
Journal of Hepatology
|
November 28, 2012
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Colloid and Interface Science
|
September 12, 2012
Microfluidic preparation and self diffusion PFG-NMR analysis of monodisperse water-in-oil-in-water double emulsions
Eric Hughes, Abid Aslam Maan, Simone Acquistapace, et al.
Antiviral Therapy
|
August 28, 2015
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)
Christophe Hézode, Laurent Alric, Ashley Brown, et al.
Journal of Gastroenterology and Hepatology
|
August 8, 2015
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients
Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Hepatology
|
March 5, 2013
Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3
Marcelo O Silva, Michelle Treitel, Donald J Graham, et al.
Journal of Hepatology
|
July 20, 2014
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C
Jean-Pierre Bronowicki, Vlad Ratziu, Adrian Gadano, et al.
Hepatology (Baltimore, Md.)
|
September 25, 2014
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C
Tariq Ahmad, Philip Yin, Jeffrey Saffitz, et al.
Page
of 5